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Background: The aim of our study was to validate a Greek translation of the Berlin Questionnaire (BQ) for
obstructive sleep apnoea syndrome (OSAS) and to explore whether this screening questionnaire could be used to
help identify primary care patients at greater risk of having OSAS.
Methods: We recruited 189 patients visiting a primary health care setting on the island of Crete, Greece. They all
completed the Greek Version of the BQ. Patients were then referred to a Sleep Disorders Unit for evaluation of
suspected sleep-disordered breathing.
Results: A PSG study was performed in 129 of the 189 subjects (68.3%). BQ identified 74.4% (n = 96) of the patients
as high-risk for OSAS and the remaining 25.6% (n = 33) as low-risk. The sensitivity and specificity of BQ for OSAS
diagnosis were 76% and 40%, respectively, for an apnoea–hypopnoea index (AHI) ≥5 per hour but <15 per hour,
84% and 61% for an AHI ≥15 per hour but ≤30 per hour, and 79% and 39% for an AHI >30 per hour.
Conclusions: In conclusion, the Greek Version of the BQ is a useful instrument for identifying patients at risk for
OSAS in primary health care in Greece. The findings of our study confirm that such screening tools should be used
by primary care clinicians for OSAS prediction.
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validationBackground
Obstructive sleep apnoea syndrome (OSAS) is a com-
mon disease that is characterised by repetitive episodes
of partial or complete upper-airway obstruction during
sleep, leading to adverse consequences for both health
and quality of life [1-5]. It is currently estimated that at
least 1 in 5 American adults has some degree of sleep
apnoea, while 1 in 15 has moderate or severe disease [6].
Most epidemiological studies of the prevalence of ob-
structive sleep apnoea have been performed in North
America, Europe, or Australia. However, as the awareness
that OSAS can lead to serious medical sequelae is increa-
sing, several studies have been undertaken to estimate the
disease burden in other countries, such as China, India,
and Korea. Unfortunately, studies investigating the* Correspondence: izolthi@gmail.com
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distribution, and reproduction in any mediumprevalence of OSAS in Greece are lacking. Furthermore,
the majority of patients with OSAS remain undiagnosed. In
fact, in the Wisconsin Sleep Cohort Study, it was estimated
that 93% of women and 82% of men with moderate to se-
vere OSAS are undiagnosed [7]. Therefore, as our under-
standing of the prevalence and pathophysiology of OSAS
expands, clinicians should evaluate patients with OSAS
with a view to preventing these potential consequences.
The gold standard for the diagnosis of OSAS is attended
overnight polysomnography (PSG) [8]. A reliable and
easy-to-use screening tool is required for efficient predic-
tion of OSAS, helping to prioritize patients who require
sleep study according to the probability of suffering from
OSAS. Such a screening tool would give treatment to
those who are with more severe OSAS first. Meanwhile, it
would have enhanced the cost effective management of
disease especially with limited resources in our society. A
number of techniques have been purposed to be used as
screening tools for OSAS, such as questionnaires andtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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findings suggestive of OSAS, or different OSAS risk fac-
tors [9,10].
There are several OSAS questionnaires available as
screening tools to identify patients at risk for OSAS. How-
ever, it is important to remember that these questionnaires
are screening tools only and cannot replace a thorough
history and physical or objective sleep-laboratory eva-
luation. The Berlin questionnaire (BQ) is one of the
commonly known questionnaires for OSAS and has been
validated in the primary care setting [11]. It has 10
questions organised into three categories. It incorporates
questions about risk factors for sleep apnoea, such as sno-
ring behaviour, wake-time sleepiness or fatigue, and the
presence of obesity or hypertension. The BQ was origi-
nally developed in English and needs to be translated in
other languages so that it can be applied in other countries
and contexts. The aim of our study was to develop a
Greek version of the BQ and to explore whether this
screening questionnaire could be used to help identify pri-
mary care patients at greater risk of having OSAS, by
comparing the BQ score with the apnoea–hypopnoea
index (AHI) obtained from a formal sleep study.
Methods
Translation of BQ into Greek
After consent had been obtained from the developer of
the BQ, it underwent a process of translation, back trans-
lation, and final review of obtained versions, according to
the standard back translation methodology [12]. The
questionnaire was translated into Greek by two bilingual
translators working independently, thus generating two
Greek versions, which were then translated back into
English by another two bilingual individuals. The back
translations were compared with the original English so
that any necessary adjustments could be made, resulting
in a single Greek BQ version that would be equivalent in
meaning to the original (Additional file 1).
A cognitive debriefing was conducted by 2 independent
interviewers with a group of 10 individuals, in order to test
alternative wordings and to check the comprehensibility,
interpretation, and cultural relevance of the translation.
Patients
We performed a prospective study involving consecutive
primary care patients, between 18 and 65 years old, who
visited the General Hospital/Health Centre of Neapolis,
Crete, Greece. Patients with no known history of any
sleep disorder, competent to sign informed consent and
agreeable to participating in the study were included.
Patients with a prior diagnosis or treatment of OSAS,
myocardial infarction, heart failure, stroke, neurological
or psychiatric disorders, history of alcoholism, or upper
respiratory tract infection within the past one week,were excluded, as were pregnant or critically ill patients,
and subjects who did not consent to complete a sleep
study, full clinical and anthropometric examinations, and
the Greek version of the BQ. The group of patients that
met inclusion criteria was then referred to the Sleep Disor-
ders Unit, Department of Thoracic Medicine, University
of Crete Medical School, between January and December
2011, for evaluation of suspected sleep-disordered breath-
ing. All subjects provided written informed consent and
ethical approval was obtained from both the University
Hospital Ethics Committee and the General Hospital/
Health Centre of Neapolis Scientific Board.
Study subjects underwent a detailed evaluation that
included clinical history focused on sleep-related symp-
toms, associated conditions and comorbidities; they also
completed the translated Greek BQ. Excessive daytime
sleepiness was determined using the Epworth sleepiness
scale (ESS) [13]. The results of the questionnaire were
compared with polysomnography, which is considered
the gold standard for OSAS diagnosis.
Polysomnography
All patients underwent a single-night full diagnostic PSG
according to standard techniques, with monitoring of
the electroencephalogram (EEG) using frontal, central
and occipital leads, electro-oculogram (EOG), electro-
myogram (EMG), flow (by oronasal thermistor and nasal
air pressure transducer), thoracic and abdominal respira-
tory effort (induction plethysmography), oximetry, and
body position. Snoring was recorded by a microphone
placed on the anterior neck. Polysomnographic record-
ings were manually interpreted over 30-second periods,
in accordance with the the new American Academy of
Sleep Medicine (AASM) guidelines [14]. The scorer was
always the same, blinded to the clinical condition of the
patients and the previous results of the questionnaire.
The determination of sleep stages and arousals was per-
formed according to the AASM 2007 criteria, using EEG
montages including frontal, central and occipital leads. The
definition of apneas and hypopneas followed the AASM
recommended criteria [14]. The AHI, calculated as the
number of apnoea and hypopnoea events per hour of sleep
was used for OSAS diagnosis and severity. OSAS was con-
sidered mild if the AHI was ≥5 per hour but <15 per hour,
as moderate if AHI was ≥15 per hour but >30 per hour and
as severe if AHI was >30 per hour.
BQ score
The BQ contains 10 questions covering three categories
including: 1) snoring severity (items 1–5), 2) excessive
daytime sleepiness (items 6–9), and 3) history of high
blood pressure or obesity (item 10). The questionnaire
also includes information about age, sex, height, weight,
and neck size. The patient is instructed to answer
Table 1 Characteristics of the study population (n = 189)
Characteristics
Age, years 47 ± 13
Male gender, n (%) 117 (61.9)
Epworth sleepiness scale 10 ± 6
Hypertension (≥140/90 mmHg), n (%) 51 (26.9)
Body mass index (kg/m2) 35.0 ± 25.1
Normal (18.5 – 24.9), n (%) 30 (15.9)
Overweight (25 – 29.9), n (%) 56 (29.6)
Obese (≥30), n (%) 103 (54.5)
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medical staff is needed to analyse the responses. The BQ
was scored (Additional file 1) as previously reported by
Netzer and colleagues [11]. The first two categories are
positive (one point is assigned) if responses indicate
persistent symptoms (>3–4 times a week) on the ques-
tionnaire items. Item 5, about witnessed apnoeas, is an
exception where a positive response is awarded two
points. Category 2 includes an additional item concerning
frequency of drowsiness behind the wheel (item 9) for
which no point is assigned. Categories 1 and 2 are positive
when the sum of all items is equal to or greater than 2,
while category 3 is positive if the patient has high blood
pressure and/or is obese (body mass index, BMI > 30). If
the individual scores positive in at least 2 of the 3 categor-
ies, the patient is found to be at high risk for OSAS. How-
ever, if the patient scores positive in only one or none of
the categories, then the patient is deemed to be at low risk
for OSA.Statistical analysis
Basal characteristics were described as mean ± standard
deviation for quantitative variables and as counts for
proportions. Sensitivity, specificity, predictive values,
likelihood ratio, odds ratio and their 95% confidence
intervals, and the area under the curve (AUC) for each
cut-off value of the diagnosis gold standard were calcu-
lated using standard methods by comparison with the
PSG results. The Pearson correlation coefficient and
level of significance were used to compare BQ score and
risk groupings. The software SPSS 17.0.0 (Chicago IL,
USA) was used. Probability values of p < 0.05 were con-
sidered as statistically significant.Table 2 Polysomnography (PSG) findings and Berlin
Questionnaire findings in the 129 patients who
completed the PSG study
PSG study
AHI, events per hour 41 ± 32
<5, n (%) 11 (8.5)
≥5– < 15, n (%) 20 (15.5)
≥15–≤ 30, n (%) 30 (23.3)
>30, n (%) 68 (52.7)
Mean SaO2, % 92 ± 4
Minimum SaO2, % 80 ± 9
Berlin Questionnaire (numbers of patients who were positive in
each category)
Category 1, n (%) 117 (90.7)
Category 2, n (%) 54 (41.9)
Category 3, n (%) 97 (75.2)
SaO2: peripheral arterial oxygen saturation.Results
General characteristics of the population
We evaluated 189 primary care patients. Men made up
61.9% (n = 117) of the population, while 38.1% were
women (n = 72). Ages ranged between 25 and 65 years
(47 ± 13). The characteristics of the study population are
given in Table 1. One hundred and three (54.5%)
patients were obese (BMI > 30). Fifteen patients (7.9%)
had a history of chronic obstructive pulmonary disease,
51 (26.9%) had systemic arterial hypertension and 16
(8.5%) diabetes mellitus.
A PSG study was performed in 129 of the 189 subjects
(68.3%). Further analysis was performed only in these
129 patients, and the remained 60 patients were
excluded. The diagnosis of OSAS was confirmed in
91.5% of these 129 subjects (n = 118). Table 2 depicts
PSG findings and Berlin Questionnaire findings in these
129 patients (Table 2).Association between BQ score and AHI
BQ identified 74.4% (n = 96) of the patients as being at high
risk of having OSAS and the remaining 25.6% (n = 33) as at
low risk (Table 3). Table 3 shows the number of individuals
with positive (high risk of sleep apnoea) and negative (low
risk of sleep apnoea) scores on the BQ in each AHI range.
For patients with a high risk score the OSAS diagnosis was
confirmed by PSG study in 93.75% (n = 90). Thus, high-risk
patients were more likely to have an ΑΗΙ of ≥ 5 and hence
meet the criteria for OSAS. On the other hand, in those
with a low-risk score, the OSAS diagnosis was excluded in
only 15.2% (n = 5). Furthermore, a good positive and highly
significant correlation was found between AHI and BQ
score (Fisher’s exact test, p < 0.05), for AHI ≥ 15–≤ 30,
meaning that the AHI scores were higher in the group
identified as being at high risk of having sleep apnoea by
the BQ.
BQ performance
Various cut-off values for AHI were used to stratify the
patients in groups in relation to the severity of OSAS, as
Table 3 Relationship between Berlin questionnaire score
and apnoea–hypopnoea index (AHI)
AHI (n/h) Low risk, n (%) High risk, n (%)
<5 5 (15.2) 6 (6.3)
≥5– < 15 14 (42.4) 6 (6.3)
≥15– ≤ 30 9 (27.3) 22 (22.9)
>30 5 (15.2) 62 (64.6)
Total, n 33 96
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for OSA diagnosis were 76% and 40%, respectively, for an
AHI ≥ 5–< 15, 84% and 61% for an AHI ≥ 15–≤ 30, and
79% and 39% for an AHI > 30 (Table 4). The AUC
obtained for AHI ≥ 15– ≤ 30 was 0.72 (95% CI: 0.64 –
0.80, p < 0.0001) on the Receiver Operating Characteristic
(ROC) curve. This means that the probability that the BQ
score predicted AHI ≥ 15–≤ 30 correctly was 72%. The
AUC was only 0.58 (CI 95%: 0.49 – 0.67, p = 0.38) for
detecting AHI ≥ 5–< 15 and 0.59 (CI 95%: 0.5 – 0.67,
p = 0.13) for detecting AHI > 30.
Discussion
As the field of sleep medicine advances and more
patients are diagnosed with OSAS and other sleep dis-
orders, primary care clinicians will need to be able to
recognise, diagnose, and treat these conditions. Recog-
nizing sleep complaints is often challenging for both
patients and clinicians. Although a polysomnogram is
required to establish the diagnosis of OSAS, the long
waiting lists for PSG in sleep centres have created inter-
est in screening tools for obstructive sleep apnoea.
While each of these has its own strengths and limita-
tions, they all basically focus on similar high-risk
features, such as habitual snoring, witnessed apnoeas, a
high BMI, male sex, and advanced age. One validated
tool that can help identify those with OSAS is the BQ.
BQ is useful in screening sleep apnoea in a primary care
population and may be more convenient and less costly
than PSG.Table 4 Predictive parameters for BQ
AHI ≥ 5 – <15 (95% CI)
Sensitivity, % 76 (67–73)
Specificity, % 40 (12–74)
PPV, % 94 (86–96)
NPV, % 12 (3.5–28.2)
Positive LR 1.26 (0.6–27)
Negative LR 0.61 (0.3–1.1)
Odds ratio 2.069 (0.54–7.8)
AUC 0.578 (0.488–0.665)
AHI: apnoea/hypopnoea index; AUC: area under the curve; BQ: Berlin Questionnaire;
predictive value.Our investigation showed that, for different AHI cut-
off points, BQ showed a moderate to high sensitivity
(76–84%), a specificity that was low to moderate (40–61%),
and a low positive likelihood ratio (1.26 to 2.14). However,
positive predictive value is high (80–94%), indicating that if
BQ is positive, for example at an AHI ≥ 5–< 15, there is a
high (94%) likelihood that a person would actually have
sleep apnea. We found a higher sensitivity and specificity
when AHI was between 15 and 30. This finding suggests
that in primary care patients, the Berlin questionnaire can
be helpful in detecting a high risk of having OSAS, espe-
cially if the OSAS is moderate or severe.
The BQ is widely used as a screening tool for OSAS. It
was an outcome of the Conference on Sleep in Primary
Care in April 1996 in Berlin, Germany. The BQ is a
standardised, self-administered questionnaire developed
for assessing subjects at high risk for OSAS. It is inex-
pensive, easy to administer and has acceptable test–retest
reliability [11,15,16]. This instrument has been used
worldwide, such as in the USA [11], Jordan [17], and
Nigeria [18]. In addition, it has been used for OSAS
screening in surgical patients before anaesthesia [19], in
patients undergoing endoscopy [20], as well as among or-
chestra members [21] or to predict outcomes after the
catheter ablation of atrial fibrillation [22].
The predictive performance of the BQ varies among
different patient populations. Our results are consistent
with those reported by Netzer et al. [11], who also vali-
dated the BQ in a primary care population. The sensitiv-
ity and specificity obtained by Netzer and colleagues
were 54% and 97%, respectively, at a cut-off of AHI ≥ 15
[11]. However, these sensitivity and specificity values
have been criticised [15] as being erroneous, and it has
been suggested that the actual sensitivity and specificity
for Netzer’s study were 95% and 48%, respectively. Fur-
thermore, in the Netzer manuscript, specificity increased
as the AHI threshold increased and sensitivity fell. In
our study, the sensitivity and specificity does not change
very much at AHI ≥ 5, 15, 30, compared to the previous
study. This may be due to several reasons. First, theAHI ≥ 15 – ≤ 30 (95% CI) AHI > 30 (95% CI)
84 (76–91) 79 (69–86)
61 (41–79) 39 (22–58)
86 (80–94) 80(71–87)
52 (34–69) 36 (20–55)
2.14 (1.6–2.9) 1.28 (0.8–2.0)
0.26 (0.1–0.5) 0.55 (0.3–0.9)
8.21 (3.2–20.8) 2.31 (0.97–5.5)
0.724 (0.639–0.799)* 0.586 (0.496–0.672)
LR: likelihood ratio; NPV: negative predictive value; PPV: positive
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offered to both high risk and lower risk patients, but
more patients at high risk, who had sleep symptoms, se-
lectively consented to the overnight polysomnography.
Secondly, in the Netzer study, portable monitoring was
used to assess the validity of the risk grouping strategy,
compared to attended overnight polysomnography used
in our study, which is the gold standard for the diagnosis
of OSAS.
Apart from the Netzer study, previous studies exploring
the BQ as an instrument to detect sleep apnoea showed
similar or lower sensitivity and specificity compared to our
results. The performance of the BQ in our population is in
accordance with results obtained in other studies under-
taken in a sleep laboratory in Portugal (72% and 50% for
AHI ≥ 5– < 15, 82% and 45% for AHI ≥ 15– ≤ 30, and 88%
and 39% for AHI > 30) [23], in a hypertension clinic (86%
and 65% for AHI > 10) [24], and in preoperative patients
(69% and 56% for AHI ≥ 5– < 15, 79% and 51% for AHI ≥
15– ≤ 30, and 87% and 46% for AHI > 30) [19]. A better
sensitivity of 86% and a specificity of 95% at a cut-off of
AHI ≥ 5 were found when a modified version of the Berlin
questionnaire was used [25] and in the Arabic version of
the BQ (sensitivity of 97% and specificity of 90%) [26].
On the other hand, the results of our study differ from
some others in the literature, where the BQ was shown to
detect sleep apnoea in patients referred to a sleep labora-
tory with a lower sensitivity and specificity (68% and 49%
for AHI ≥ 5, 62% and 43% for AHI ≥ 10, and 57% and 43%
for AHI ≥ 15) [16], and in patients undergoing pulmonary
rehabilitation (sensitivity and specificity 62.5% and 53.8%
with a cut-off for AHI of 10 or greater) [27].
In our study, BQ demonstrated moderate to high sen-
sitivity and low to moderate specificity: however, primary
care practitioners require a practical and sensitive
screening tool to identify patients at high risk of having
OSAS. Because of the high prevalence of OSAS in pri-
mary care patients and the growing awareness of OSAS,
general practitioners (GPs) are dealing with increasing
numbers of patients with OSAS. Many patients who visit
primary care physicians report risk factors, such as obes-
ity and hypertension, and symptoms, such as snoring,
sleepiness, and tiredness, suggestive of sleep apnoea.
However, primary care providers often do not investigate
these symptoms, and sleep apnoea frequently goes un-
diagnosed. Using the BQ as a screening tool for sleep ap-
noea in primary care population seems acceptable, being
more convenient and less costly for health care users.
On the other hand, with the increased awareness of
OSAS comes the risk that primary care physicians will
refer patients with complaints of poor sleep, daytime
sleepiness, and fatigue to sleep laboratories, without
considering other diagnoses, such as insomnia, depres-
sion, and hypothyroidism [28,29]. Furthermore, excessivedaytime sleepiness is a common complaint both in
sleep-disordered patients and in a number of other non-
medical and medical conditions, such as a shortage of
sleep due to social or family reasons, shift working [30]
or daytime non-shift working [31], and neurological dis-
orders [32,33]. Therefore, given the need for stratifica-
tion to determine patients who urgently require sleep
studies, and in the face of rising health care costs and
increased pressure for the more stringent control of
health care resources, it would clearly be beneficial if
primary care physicians could rely upon screening ques-
tionnaires to identify patients who are likely to have
sleep apnoea, recommending sleep studies only for those
patients who are at high risk of having a sleep disorder.
In addition, most sleep clinics have long waiting lists,
whereas patients who may have severe sleep breathing
disorders warrant quicker diagnosis and treatment.
Our study presents some limitations that deserve com-
ment. Firstly, there is a possible bias associated with the
self-selection of patients. We found a high prevalence of
OSAS in our group (91.5%), which is higher than esti-
mates from community based surveys and is similar to
the estimates found in surveys in sleep laboratories. As
already mentioned, there may have been self-selection
by the patients because those who had sleep symptoms
might have selectively consented to the overnight poly-
somnography. Secondly, the mean BMI of the popula-
tion in this study was high, with many patients being
overweight and obese (29.6% and 54.5% respectively).
The higher than average BMI of the sleep clinic popula-
tion was likely to have affected the sensitivity and speci-
ficity of the BQ, as the BMI also factors heavily into the
scoring of the BQ.
Conclusions
In conclusion, our study confirms the importance of ques-
tionnaires in OSAS screening. These tools are inexpensive
and easy to apply and should be used as a screening test
in clinical practice. Due to the relatively high prevalence of
undiagnosed OSAS and its complications for health, pri-
mary care clinicians need a reliable screening tool for
OSAS prediction. Using the BQ, they could detect the
possibility of OSAS during usual day practice visits and
then identify high-risk groups of patients who should
therefore be referred for further examination.
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